Authors:
Prehn, JL
Landers, C
Muller, GW
Man, HW
Stirling, DI
Targan, SR
Citation: Jl. Prehn et al., Potent inhibition of cytokine production from intestinal lamina propria T cells by phosphodiesterase-4 inhibitory thalidomide analogues, J CLIN IMM, 21(5), 2001, pp. 357-364
Authors:
Teo, SK
Scheffler, MR
Kook, KA
Tracewell, WG
Colburn, WA
Stirling, DI
Thomas, SD
Citation: Sk. Teo et al., Thalidomide dose proportionality assessment following single doses to healthy subjects, J CLIN PHAR, 41(6), 2001, pp. 662-667
Authors:
Davies, FE
Raje, N
Hideshima, T
Lentzsch, S
Young, G
Tai, YT
Lin, B
Podar, K
Gupta, D
Chauhan, D
Treon, SP
Richardson, PG
Schlossman, RL
Morgan, GJ
Muller, GW
Stirling, DI
Anderson, KC
Citation: Fe. Davies et al., Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma, BLOOD, 98(1), 2001, pp. 210-216
Authors:
Teo, SK
Scheffler, MR
Kook, KA
Tracewell, WG
Colburn, WA
Stirling, DI
Thomas, SD
Citation: Sk. Teo et al., Effect of a high-fat meal on thalidomide pharmacokinetics and the relativebioavailability of oral formulations in healthy men and women, BIOPHARM DR, 21(1), 2000, pp. 33-40
Authors:
Hideshima, T
Chauhan, D
Shima, Y
Raje, N
Davies, FE
Tai, YT
Treon, SP
Lin, B
Schlossman, RL
Richardson, P
Muller, G
Stirling, DI
Anderson, KC
Citation: T. Hideshima et al., Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy, BLOOD, 96(9), 2000, pp. 2943-2950
Authors:
Corral, LG
Haslett, PAJ
Muller, GW
Chen, R
Wong, LM
Ocampo, CJ
Patterson, RT
Stirling, DI
Kaplan, G
Citation: Lg. Corral et al., Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha, J IMMUNOL, 163(1), 1999, pp. 380-386